Background Data on patients with COVID-19 who have cancer are lacking. Here we
characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify …

PURPOSE Variation in risk of adverse clinical outcomes in patients with cancer and COVID-
19 has been reported from relatively small cohorts. The NCATS'National COVID Cohort …

Background Individuals with cancer, particularly those who are receiving systemic
anticancer treatments, have been postulated to be at increased risk of mortality from COVID …

Background Emerging data suggest variability in susceptibility and outcome to coronavirus
disease 2019 (COVID-19) infection. Identifying risk factors associated with infection and …

PURPOSE SARS-CoV-2 (COVID-19) is a systemic infection. Patients with cancer are
immunocompromised and may be vulnerable to COVID-related morbidity and mortality. The …

Importance Whether the severity and mortality of COVID-19 in patients with cancer have
improved in terms of disease management and capacity is yet to be defined. Objective To …

Background The medium-term and long-term impact of COVID-19 in patients with cancer is
not yet known. In this study, we aimed to describe the prevalence of COVID-19 sequelae …

Background Patients with cancer are a high-risk population in the COVID-19 pandemic. We
aimed to describe clinical characteristics and outcomes of patients with cancer and COVID …

Importance As the COVID-19 pandemic continues, understanding the clinical outcomes of
patients with cancer and COVID-19 has become critically important. Objective To compare …

The 1‐year mortality and health consequences of COVID‐19 in cancer patients are relatively
underexplored. In this multicenter cohort study, 166 COVID‐19 patients with cancer were …